Постановление Правительства РФ от 19 июня 1994 года №706 «Об утверждении. Инструкция от 21 июля 1992 года № 01 - 19 / 9 - 11 О порядке.
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 19-9 (190. 30). Benefit Category.
Руководство пользователя ECA. Manual 01 19 60015. 9. Отправляется, когда. 01 19 60015. 15. 11 Запустите настройки ярлыка ECA. Инструкция ГК СЭН РФ 01 - 19 / 9 - 11 -92 Отбор проб. Инструкция по санитарно-микробиологическому контролю производства пищевой продукции из. 11, Методические рекомендации по изучению белкового статуса и 18, Инструкция о работе санитарно-эпидемиологических станций по контролю за. и на предприятиях общественного питания, N 01 — 19 / 9 — 11 ГКСЭН. Духовка бош инструкция по эксплуатации фильтр пресс инструкция стоматологической медицинской сестры инструкция 01 19 9 11 92 р.
Diagnostic Laboratory Tests. Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service. Item/Service Description. Immunoassay determinations of the serum levels of certain proteins or carbohydrates serve as tumor markers. When elevated, serum concentration of these markers may reflect tumor size and grade. This policy specifically addresses the following tumor antigen: CA 19-9.
Indications and Limitations of Coverage. Multiple tumor markers are available for monitoring the response of certain malignancies to therapy and assessing whether residual tumor exists post-surgical therapy. Levels are useful in following the course of patients with established diagnosis of pancreatic and biliary ductal carcinoma. The test is not indicated for diagnosing these two diseases. These services are not covered for the evaluation of patients with signs or symptoms suggestive of malignancy. The service may be ordered at times necessary to assess either the presence of recurrent disease or the patient's response to treatment with subsequent treatment cycles. Note: Scroll down for links to the quarterly Covered Code Lists (including narrative).
Cross Reference. Also see the Medicare Claims Processing Manual, Chapter 120, Clinical Laboratory Services Based on Negotiated Rulemaking.